Optimization of drug-eluting balloon use for safety and efficacy: Evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 3, 2010, Pages 395-403

  Pósa, Anikó ^a   Nyolczas, Noemi ^a   Hemetsberger, Rayyan ^a   Pavo, Noemi ^a   Petnehazy, Örs ^b   Petrasi, Zsolt ^b   Sangiorgi, Giuseppe ^c   Gyöngyösi, Mariann ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b SZENT ISTVÁN UNIVERSITY   (Hungary)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Angioplasty; Catheterization; Coronary disease; Follow up studies; Revascularization

Indexed keywords

PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTERY INJURY; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; BALLOON; BALLOON DILATATION; CONTROLLED STUDY; CORONARY ARTERY; DISEASE MODEL; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELUTING BALLOON; DRUG ELUTING STENT; DRUG PENETRATION; DRUG SAFETY; DRUG TISSUE LEVEL; EPITHELIUM HYPERPLASIA; FLUORESCENCE; FOLLOW UP; HISTOPATHOLOGY; NONHUMAN; SWINE;

ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; CORONARY VESSELS; EQUIPMENT DESIGN; HYPERPLASIA; MATERIALS TESTING; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; PACLITAXEL; SUS SCROFA; TISSUE DISTRIBUTION; TUNICA INTIMA;

EID: 77956828009     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22468     Document Type: Article

References (26)

1. Scheller B, Speck U, Schmitt A, Böhm M, Nickenig G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol 2003;42:1415-1420. (Pubitemid 37267283)
2. Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004;110:810-814.
3. Scheller B, Speck U, Schmitt A, et al. Acute cardiac tolerance of current contrast media and the new taxane protaxel using iopromide as carrier during porcine coronary angiography and stenting. Invest Radiol 2002;37:29-34. (Pubitemid 34027842)
4. Speck U, Scheller B, Abramjuk C, Grossmann S, Mahnkopf D, Simon O. Inhibition of restenosis in sented porcine coronary arteries: Uptake of paclitaxel from angiographic contrast media. Invest Radiol 2004;39:182-186.
5. Speck U, Scheller B, Abramjuk C, et al. Neointima inhibition: Comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 2006;240:411-418.
6. Posa A, Hemetsberger R, Petnehazy O, et al. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron Artery Dis 2008;19:243-247.
7. Scheller B, Speck U, Romeike B, et al. Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J 2003;24:1462-1467.
8. Byrne RA, Mehilli J, Iijima R, et al. A polymer-free dual drug-eluting stent in patients with coronary artery disease: A randomized trial vs. polymer-based drug-eluting stents. Eur Heart J 2009;30:923-931.
9. Schwartz RS, Edelman ER for the Consensus Committee. Drug-eluting stents in preclinical studies. Recommended evaluation from a Consensus Group. Circulation 2002;106:1867-1873.
10. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol 1999;10:499-506.
11. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the propor- tional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 1992;19:267-274.
12. Rosenthal EA, Bohlmeyer TJ, Monnet E, MacPhail C, Robertson AD, Horwitz MA, Burchenal JEB, Horwitz LD. An iron-binding exochelin prevents restenosis due to coronary artery balloon injury in a porcine model. Circulation 2001;104:2222-2227. (Pubitemid 33043304)
13. Patterson C, Mapera S, Li H, et al. Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: Role of Akt-dependent signaling. Arterioscler Thromb Vasc Biol 2006;26:1473-1480.
14. Herdeg C, Oberhoff M, Baumbach A, et al. Local paclitaxel delivery for the prevention of restenosis: Biological effects and efficacy in vivo. J Am Coll Cardiol 2000;35:1969-1976.
15. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-2124. (Pubitemid 44749319)
16. Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-2994.
17. Scheller B, Hehrlein C, Bocksch W, et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2008;97:773-781.
18. De Labriolle A, Pakala R, Bonello L Lemesle G, Scheinowitz M, Waksman R. Paclitaxel-eluting balloon: From bench to bed. Catheter Cardiovasc Interv 2009;73:643-652.
19. Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: The DEBIUT (Drug-Eluting Balloon in Bifurcation Utrecht) registry. Catheter Cardiovasc Interv 2008;71:629-635.
20. Gyöngyösi M, Nyolczas N, Badr-Eslam R, et al. Comparison of 1-year clinical outcomes of treatment of instent restenosis with Cypher or Taxus stents or Dior paclitaxel-eluting balloon. Eur Heart J 2009;31:(abstract).
21. Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 2001;104:600-605. (Pubitemid 32738132)
22. Iofina E, Langenberg R, Blindt R, Kühl H, Kelm M, Hoffmann R. Polymer-based paclitaxel-eluting stents are superior to non-polymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions. Am J Cardiol 2006;98:1022-1027.
23. Albrecht T, Speck U, Baier C, Wolf KJ, Böhm M, Scheller B. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol 2007;42:579-585. (Pubitemid 47051835)
24. Cremers B, Speck U, Kaufels N, et al. Drug-eluting balloon: Very short-term exposure and overlapping. Thromb Haemost 2009;101:9-11.
25. Farhan S, Hemetsberger R, Matiasek J, Strehblow C, Pavo N, Khorsand A, Petneházy O, Petrási Z, Kaider A, Glogar D, Huber K, Gyöngyösi M. Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model. Atherosclerosis 2009;202:144-151.
26. Kollum M, Farb A, Schreiber R, Terfera K, Arab A, Geist A, Haberstroh J, Wnendt S, Virmani R, Hehrlein C. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Catheter Cardiovasc Interv 2005;64:85-90. (Pubitemid 40069896)